AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Gilead Sciences (GILD) is expected to exceed Q1 2025 earnings estimates, with a Most Accurate Estimate of $1.78 per share surpassing the Zacks Consensus Estimate of $1.71. Analysts forecast an average stock price increase of over 8% from current levels. However, GuruFocus' GF Value suggests a potential downside of 21.22% from the current price of $102.16.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet